Injeq Oy Shares Have Been Transferred to Finnish Book-Entry Securities System – Instructions for Shareholders

Injeq Oy Annual General Meeting resolved on 26th May 2021 to transfer the shares of the company into the Finnish book-entry securities system. Appropriate instructions were sent to all shareholders by email in June 2021 and on 16th September 2021 the shares were incorporated in the book-entry system. In case you have not received the said instructions, or your shares have not been transferred for some other reason, we ask you to contact ir@injeq.com for instructions.

The transfer to the Finnish book-entry securities system means that the maintenance of the Company’s shareholder register has been transferred to Euroclear Finland Ltd. A shareholder may not use shareholder rights in the Company before the shareholder has been registered in the shareholders’ register maintained in Euroclear Finland Ltd. The shareholding of each shareholder will be entered into the shareholder’s personal book-entry account in connection with the transfer to the Finnish book-entry securities system.

If your place of residence is outside Finland and your foreign bank can’t take into custody unlisted Finnish securities, and you are unwilling or unable to open a book-entry account in Finland, you do not need to do anything at this point – your ownership will remain unchanged. If the Company’s securities are listed in the future, this should allow your bank to then take custody of your newly listed securities.

For any questions or to update your contact information for future use please do not hesitate to contact us at ir@injeq.com.

Board of Directors of Injeq Oy

Tiedote osakkeenomistajille / Notice to shareholders

TIEDOTE INJEQ OYJ:N OSAKKEENOMISTAJILLE NOTICE TO SHAREHOLDERS OF INJEQ PLC
Read more »

News release on April 12, 2024

The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »

Information to shareholders, March 22nd, 2024

Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal […]
Read more »

Injeq webinars by Dr Sauli Palmu and Dr Harri Sievänen

Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »

New distributor agreement with “GENFAX SRL”

We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »

Injeq webinar today, Thursday Feb 22nd, 2024

Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone)   Lecturers […]
Read more »